Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study

Introduction. In non-metastatic breast cancer patients, the REMAGUS02 neoadjuvant study was the first to report a significant impact of circulating tumor cells (CTCs) detection by the CellSearch system on the distant metastasis-free survival (DMFS) and overall survival (OS) endpoints. However, these...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bidard, François-Clément, Belin, Lisa, Delaloge, Suzette, Lerebours, Florence, Ngo, Charlotte, Reyal, Fabien, Alran, Séverine, Giacchetti, Sylvie, Marty, Michel, Lebofsky, Ronald, Pierga, Jean-Yves
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2013
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3665249/
https://ncbi.nlm.nih.gov/pubmed/23762567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/130470
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares